Active Ingredient History

  • Now
Imeglimin is an oral anti-diabetic medication. It was approved for use in Japan in June 2021.   Wikipedia

More Chemistry


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue